Breaking News

Novasep Names Synthesis BU President

By Kristin Brooks | January 16, 2014

Van Nieuwenhove brings extensive experience

Thierry Van Nieuwenhove has been appointed president of Novasep’s Synthesis Business Unit in Pompey, France. Mr. Van Nieuwenhove joins the company from Ajinomoto-Omnichem, a European synthetic molecules custom manufacturing organization, where he held positions as director, and general manager and member of the board. His experience includes driving business unit growth, leading global teams including sales and business development, R&D, supply chain and purchasing, as well as mergers and acquisitions.
 
“We are thrilled to welcome Thierry to Novasep as president of the Synthesis Business Unit,” said Michel Spagnol, chief executive officer of Novasep. “His broad experience in driving multicultural custom synthesis businesses will complement our COMEX skills perfectly. Thierry possesses the dynamics to boost Novasep’s CMO business in all our key markets.”
 

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016